3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8 Tsarkake>98.0% (HPLC) Favipiravir Tsakanin COVID-19

Takaitaccen Bayani:

Sunan sinadarai: 3-Hydroxypyrazine-2-Carboxamide

Saukewa: 55321-99-8

Bayyanar: Rawaya mai haske zuwa launin ruwan kasa

Tsafta:> 98.0% (HPLC)

Matsakaicin Favipiravir (CAS: 259793-96-9) a cikin maganin cututtukan mura da COVID-19

Kyakkyawan inganci, Samar da Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari 3-Hydroxypyrazine-2-Carboxamide
Makamantu T-1105;3-Hydroxy-2-Pyrazinecarboxamide;Favipiravir Desfluoro rashin tsabta;3-Oxo-3,4-dihydropyrazine-2-carboxamide
Lambar CAS 55321-99-8
Lambar CAT Saukewa: RF-PI295
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin Samarwa Har zuwa Kilogram
Tsarin kwayoyin halitta Saukewa: C5H5N3O2
Nauyin Kwayoyin Halitta 139.11
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Rawaya Mai Haske zuwa Foda Brown
Ganewa IR, HPLC
Asara akan bushewa <1.00%
Tsaftace Guda Daya <0.50%
Karfe masu nauyi ≤20ppm
Tsafta 98.0% (HPLC)
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Favipiravir (CAS 259793-96-9)

Kunshin & Ajiya:

Kunshin: kwalban, Aluminum tsare jakar, 25kg / Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi

Amfani:

1

FAQ:

Aikace-aikace:

3-Hydroxypyrazine-2-Carboxamide (CAS 55321-99-8) shine tsaka-tsaki ko ƙazanta na Favipiravir Intermediate (CAS 259793-96-9).Favipiravir sabon maganin rigakafi ne mai fadi.Ana iya amfani da Favipiravir don maganin rigakafin mura na mura A da B. Bincike ya nuna cewa baya ga cutar mura, maganin yana nuna kyakkyawan aikin rigakafin ƙwayoyin cuta na RNA iri-iri, kamar cutar Ebola, cutar fage, Bunia virus, da rabies. ƙwayar cuta.Yayin barkewar sabuwar cutar Coronavirus 2019 (COVID-19), ana iya amfani da Favipiravir wajen kula da marasa lafiya da COVID-19 da WHO ta ba da shawarar.

Ku rubuta sakonku anan ku aiko mana